| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e8d2afa63dbd8bbb90545722d3f54c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e10a1051ff252b6404cf1d17e16a34da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d1750b578ca9a780678f6b9b9c8b87d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2019-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81857c72f2268579353af1a72500cfb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_483e4803bdd7acc848ee45d2e1ee4c92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028eedc0dc8d6e474074067513b0d93d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f0411f37da4797e27d6991fe91293d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7574512f5afa14fd9ff03263dde99573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c41e55d98e11eb9f6586e161f7525d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdc4f39aaa2da330a2f738f0ec610768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139f0f86aa2dcd3368f148073752caf8 |
| publicationDate |
2020-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200068601-A |
| titleOfInvention |
Antibodies regulating functions of an endothelin receptor type A |
| abstract |
The present invention relates to a monoclonal antibody or fragment thereof that specifically recognizes and binds the extracellular region of Entothelin receptor A as an antigen. The monoclonal antibody discovered in the present invention can be usefully used as a therapeutic agent for hypertension or cancer associated with Entothelin receptor A. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200138013-A |
| priorityDate |
2018-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |